Literature DB >> 9135544

Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action.

T Tsuji1, T Yokochi, H Kamiya, Y Kawamoto, A Miyama, Y Asano.   

Abstract

In the work described here it was determined if and how unnicking in the A subunit of Escherichia coli enterotoxin at Arg192 or nearby residues affected biological activities of the toxin. The mutant toxin was constructed to lack the nick site in the A subunit by deleting the tripeptide Arg192-Thr193-Ile194, which is essential for toxicity. The mutant toxin did not exhibit agmatine ADP-ribosyltransferase activity in the presence or absence of the ADP-ribosylation factor and had less diarrhoeal activity and lower induction of cyclic AMP than did LT. The mutant toxin exhibited a much stronger adjuvant action on antibody responses to measles virus, keyhole limpt haemocyanin, bovine immunoglobulin and ovalbumin compared with LT. The altered toxicity of the mutant toxin might be closely related to the potent adjuvant action on antibody responses to antigens. The relationship between two activities is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135544      PMCID: PMC1456747          DOI: 10.1046/j.1365-2567.1997.00156.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction.

Authors:  W Ito; H Ishiguro; Y Kurosawa
Journal:  Gene       Date:  1991-06-15       Impact factor: 3.688

2.  Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.

Authors:  A Bromander; J Holmgren; N Lycke
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

3.  Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo.

Authors:  N Lycke; A K Bromander; L Ekman; U Karlsson; J Holmgren
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

4.  Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

Authors:  S Tamura; Y Samegai; H Kurata; T Nagamine; C Aizawa; T Kurata
Journal:  Vaccine       Date:  1988-10       Impact factor: 3.641

5.  Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.

Authors:  P J Van der Heijden; A T Bianchi; M Dol; J W Pals; W Stok; B A Bokhout
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

6.  Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.

Authors:  S I Tamura; H Asanuma; Y Ito; Y Hirabayashi; Y Suzuki; T Nagamine; C Aizawa; T Kurata; A Oya
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

7.  A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in a loss of its toxic activity.

Authors:  T Tsuji; T Inoue; A Miyama; K Okamoto; T Honda; T Miwatani
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

8.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.

Authors:  E Muñoz; A M Zubiaga; M Merrow; N P Sauter; B T Huber
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity.

Authors:  N Lycke; T Tsuji; J Holmgren
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

10.  Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution.

Authors:  J Moss; S J Stanley; M Vaughan; T Tsuji
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

View more
  1 in total

1.  Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.

Authors:  R Weltzin; B Guy; W D Thomas; P J Giannasca; T P Monath
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.